Evidence map›Paper›PMID 33585232›Full record

ArticleFrontiers in oncology2020

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma.

Xiaolei Wei, Jingxia Zheng, Zewen Zhang, Qiongzhi Liu, Minglang Zhan, Weimin Huang, Junjie Chen, Qi Wei, Yongqiang Wei, Ru Feng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaolei WeiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jingxia ZhengDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zewen ZhangDepartment of Hematology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Qiongzhi LiuDepartment of Hematology, Changsha Central Hospital, South China University, Changsha, China.
Minglang ZhanDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Weimin HuangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Junjie ChenDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Qi WeiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yongqiang WeiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ru FengDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic value of albumin changes between diagnosis and end-of-treatment (EoT) in diffuse large B-cell lymphoma (DLBCL) remains unknown. We retrospectively analyzed 574

Indexed as

albuminchangediffuse large B-cell lymphomaoutcomesurvival

Identifiers

PMID33585232
PMCPMC7873605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.